Skip to main content
. 2023 Feb 10;13:1117987. doi: 10.3389/fcimb.2023.1117987

Table 1.

Comparison of primary and secondary outcomes between mNGS group and non-mNGS group.

mNGS group
(n = 112)
Non-mNGS group (n = 82) p
28-day mortality 53 (47.32%) 51 (62.20%) 0.043
Total hospitalization time (d) 18 (9, 33) 13 (6, 23) 0.005
ICU hospitalization time (d) 7 (3, 15.75) 6.5 (3, 15.50) 0.355
Mechanical ventilation time (h) 29.5 (0, 193.50) 46 (0, 144) 0.709
Vasoactive drug use time (h) 27 (0, 142.5) 36 (0, 120) 0.815
90-day mortality 64 (57.14%) 57 (69.51%) 0.099